| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00234-003-1040-Y |
| P698 | PubMed publication ID | 12879326 |
| P50 | author | Adam D Waldman | Q47136991 |
| P2093 | author name string | G S Rai | |
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Magnetic resonance spectroscopy in AD. | Q30640894 | ||
| Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. | Q34049885 | ||
| 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease | Q37398623 | ||
| Multinuclear NMR studies on the energy metabolism of glial and neuronal cells | Q41587105 | ||
| Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T. | Q43556819 | ||
| Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease | Q44147111 | ||
| Quantification of neurons in Alzheimer and control brains with ex vivo high resolution magic angle spinning proton magnetic resonance spectroscopy and stereology | Q44202945 | ||
| Magnetic resonance spectroscopy and cognitive function in healthy elderly men. | Q44214940 | ||
| Clinical brain proton magnetic resonance spectroscopy for management of Alzheimer's and sub-cortical ischemic vascular dementia in older people. | Q44756810 | ||
| Probable Alzheimer disease: diagnosis with proton MR spectroscopy | Q45288947 | ||
| Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy | Q46755834 | ||
| A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression | Q48228877 | ||
| Brain MR spectroscopy at 1.0 tesla | Q48639305 | ||
| Alzheimer disease: absolute quantification of cerebral metabolites in vivo using localized proton magnetic resonance spectroscopy. | Q50135684 | ||
| Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. | Q53236578 | ||
| A 1H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis | Q62601710 | ||
| Osmoregulatory changes in myo-inositol content and Na+/myo-inositol cotransport in rat cortical astrocytes | Q71671853 | ||
| P433 | issue | 8 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| vascular dementia | Q583908 | ||
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 507-512 | |
| P577 | publication date | 2003-07-22 | |
| P1433 | published in | Neuroradiology | Q15765131 |
| P1476 | title | The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study | |
| P478 | volume | 45 |
| Q36939456 | 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment |
| Q30945792 | 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. |
| Q40285261 | Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy |
| Q46661314 | Chronic intermittent but not constant hypoxia decreases NAA/Cr ratios in neonatal mouse hippocampus and thalamus |
| Q36577350 | Clinical and cognitive correlates of the proton magnetic resonance spectroscopy measures in chronic schizophrenia. |
| Q36681486 | Detection and characterization of neurotoxicity in cancer patients using proton MR spectroscopy |
| Q37322452 | Low striatal glutamate levels underlie cognitive decline in the elderly: evidence from in vivo molecular spectroscopy |
| Q43019786 | MR spectroscopy in dementia |
| Q34325302 | Magnetic resonance spectroscopy in vivo of neurochemicals in a transgenic model of Alzheimer's disease: a longitudinal study of metabolites, relaxation time, and behavioral analysis in TASTPM and wild-type mice |
| Q45905949 | Mini-Mental State Examination and proton spectroscopy of the posterior cingulate in Alzheimer disease. |
| Q38392737 | Naming is associated with left temporal pole metabolite levels in neurodegenerative diseases. |
| Q31078864 | Neuroradiological findings in vascular dementia |
| Q44121879 | Postoperative changes in cerebral metabolites associated with cognitive improvement and impairment after carotid endarterectomy: a 3T proton MR spectroscopy study |
| Q30906513 | Prolonged rote learning produces delayed memory facilitation and metabolic changes in the hippocampus of the ageing human brain |
| Q46155330 | Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease |
| Q33462288 | Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment |
| Q49074225 | Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study |
| Q36853915 | Strategies for molecular imaging dementia and neurodegenerative diseases |
| Q37418999 | The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES). |
| Q30803093 | Various MRS application tools for Alzheimer disease and mild cognitive impairment |
Search more.